Pharming B.V.
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Industrial and Commercial Machinery and Equipment, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Pharming B.V.
Live alerts from global media, monitored by Business Radar
2015-05-18 (businessinsider.nl)
Pharming launches Ruconest access program
LEIDEN (AFN) - Pharming has launched a global access program for Ruconest together with Clinigen Group. The Leiden biotechnology company announced this on Monday. The program allows patients in countries where the drug is not commercially available to still gain access to the product, under certain conditions.
Read more
2015-05-18 (businessinsider.nl)
Pharming launches Ruconest access program
LEIDEN (AFN) - Pharming has launched a global access program for Ruconest together with Clinigen Group. The Leiden biotechnology company announced this on Monday. The program allows patients in countries where the drug is not commercially available to still gain access to the product, under certain conditions.
Read more